LJ-001
LJ-001 is a broad-spectrum antiviral small molecule active against numerous enveloped viruses, including transmissible gastroenteritis virus (TGEV) and porcine delta coronavirus (PDCoV) . It is a valuable research tool for studying viral entry mechanisms in both in vitro and in vivo infection models.
Product Specifications
CAS Number
851305-26-5
Product Name Alternative
DNA viruses, HCV, HIVProtease, HIV Protease, HIV, LJ001, LJ-001, LJ 001, RNA viruses
Field of Research
Immunology & Inflammation, Infectious Disease & Virology, Protein Biochemistry
Purity
98.02% (May vary between batches)
Solubility
DMSO:3.28 mg/mL (10.02 mM)
Smiles
C (\C=1OC (=CC1) C2=CC=CC=C2) =C\3/C (=O) N (CC=C) C (=S) S3
Molecular Formula
C17H13NO2S2
Molecular Weight
327.42
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1019670-01 0.02 mg (E-Coli)
Recombinant Brevibacillus brevis UPF0358 protein BBR47_22520 (BBR47_22520)
Sign In for Pricing
View Details 
MBS1019670-02 0.1 mg (E-Coli)
Recombinant Brevibacillus brevis UPF0358 protein BBR47_22520 (BBR47_22520)
Sign In for Pricing
View Details 
MBS1019670-03 0.02 mg (Yeast)
Recombinant Brevibacillus brevis UPF0358 protein BBR47_22520 (BBR47_22520)
Sign In for Pricing
View Details MBS1019670-04 0.1 mg (Yeast)
Recombinant Brevibacillus brevis UPF0358 protein BBR47_22520 (BBR47_22520)
Sign In for Pricing
View Details MBS1019670-05 0.02 mg (Baculovirus)
Recombinant Brevibacillus brevis UPF0358 protein BBR47_22520 (BBR47_22520)
Sign In for Pricing
View Details MBS1019670-06 1 mg (E-Coli)
Recombinant Brevibacillus brevis UPF0358 protein BBR47_22520 (BBR47_22520)
Sign In for Pricing
View Details